Rare diseases
Investigational molecules
Locations
364 conditions with trials, the busiest first
1 201 trials across Europe, recruiting first
Study on the Safety and Effectiveness of HDP-101 for Patients with Relapsed or Refractory Multiple Myeloma
GermanyStudy on Preventing Bleeding in Children with Severe von Willebrand Disease Using Vonicog Alfa and Octocog Alfa
FranceStudy of Linvoseltamab in Adults with Relapsed or Refractory Multiple Myeloma
BelgiumStudy of Gilteritinib, Venetoclax, and Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutations Not Eligible for Intensive Treatment
GermanyStudy on Emicizumab and Drug Combination for Patients with Haemophilia A and FVIII Inhibitors
BulgariaStudy of azacitidine combined with low-dose venetoclax treatment for patients with acute myeloid leukemia
DenmarkStudy of Combined Imaging with Hyperpolarized [1-13C]Pyruvate and Fludeoxyglucose (18F) for Cancer Detection in Patients with Breast Cancer, Neuroendocrine Tumors, Lymphomas, or Sarcomas
DenmarkStudy on Long-Term Safety of Pelabresib for Patients with Myelofibrosis or Essential Thrombocythemia
BelgiumStudy on the Safety and Effects of Infusing Modified CD34+ Cells for Patients with Fanconi Anemia Subtype A
SpainStudy comparing ferumoxytol and iron sucrose for treating iron deficiency anemia in children
LithuaniaStudy of Trabectedin alone versus Trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment
GermanyComparing ferumoxytol and iron sucrose for treating iron deficiency anemia in children with chronic kidney disease
HungaryThe therapies tested most often in Blood and lymphatic system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
